Literature DB >> 10369199

The estrogen receptor family.

M Warner1, S Nilsson, J A Gustafsson.   

Abstract

A significant flow of new data is currently being generated within the field of estrogen receptors and their mechanisms of action. This is primarily a result of the development of estrogen receptor knockout mice and the discovery of the second estrogen receptor, estrogen receptor beta. Both estrogen receptors appear to be involved in a multitude of regulatory events, the details of which will be worked out within the next few years. Estrogen receptor alpha appears to play a major role in the regulation of reproductive events and estrogen receptor alpha knockout female mice are completely infertile. Estrogen receptor beta knockout females have severe but incomplete infertility. Estrogen receptor beta gene mutations may, therefore, be of great clinical interest because they could perhaps explain some cases in which ovarian dysfunction leads to human infertility. Both receptors appear to be of essence for the cardiovascular system. Future studies will determine the relative importance of estrogen receptors alpha and beta in bone, the urogenital tract, the immune system, and the central nervous system, as well as in other estrogen target tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369199     DOI: 10.1097/00001703-199906000-00003

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  27 in total

1.  Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells.

Authors:  M K Tikkanen; D J Carter; A M Harris; H M Le; D O Azorsa; P S Meltzer; F E Murdoch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.

Authors:  D C Márquez; J Lee; T Lin; R J Pietras
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

3.  Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.

Authors:  Elizabeth A Fogarty; Christina K Matulis; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

Review 4.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

5.  Computational method for discovery of estrogen responsive genes.

Authors:  Suisheng Tang; Sin Lam Tan; Suresh Kumar Ramadoss; Arun Prashanth Kumar; Man-Hung Eric Tang; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

Review 6.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

7.  Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus.

Authors:  Z Weihua; S Saji; S Mäkinen; G Cheng; E V Jensen; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.

Authors:  Miao Sun; Gary D Isaacs; Nasun Hah; Nina Heldring; Elizabeth A Fogarty; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2012-03-22

9.  Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.

Authors:  Seetharaman Balasenthil; Ratna K Vadlamudi
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

10.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.